7 results
IDSA Recommendations for Treating Mucosal Candidiasis in HIV-AIDS
Oropharyngeal Candidiasis: Initial Episodes (Duration of Therapy: 7–14 days)
Preferred
IDSA Recommendations ... suspension 4–6 mL ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology
Vancomycin Associated Acute Kidney Injury

 • Drug induced acute kidney injury is generally defined as a
increase of 44 mol ... Treatment includes prevention ... Vancomycin #AKI #pharmacology ... #toxicology #diagnosis ... #management #nephrology
Diuretics and Agents Regulating Renal Excretion

Carbonic Anhydrase Inhibitors (Acetazolamide, Dichlorphenamide)
 • Glaucoma
 • Epilepsy
 • Altitude
disequilibrium syndrome • Diagnosis ... irrigation • Management ... Excretion #Diuresis #Nephrology ... #Pharmacology # ... Medications #Table
It is important to recognize Acute Decompensated Heart Failure (ADHF) as more than just simply a
then be excreted using ... then placed on prevention ... #algorithm #management ... cardiology #treatment #table ... icu #clinical #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... please refer to Table ... 5 for dosing recommendation ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Preventing and Treating Varicella Zoster Virus (VZV) Infections in HIV-AIDS
Pre-Exposure Prevention of VZV
IDSA Recommendations ... health-care provider diagnosis ... , 2 doses (0.5 mL ... #management #opportunistic ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
and molecular diagnostic ... Please refer to the table ... #Prevention #Treatment ... #management #opportunistic ... infections #HIVAIDS #pharmacology